Amesite Inc.

For the period ended Dec 31, 2025. Filed Feb 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Dec 31, 2025 · Filed Feb 6, 2026

AMST$0.48-9.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Cash Flows (unaudited)

	For the Six Months Ended
	December 31,
2025 · 2024
Cash Flows from Operating Activities
Net Loss		$(1,374,814)	$(2,029,682)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		128,180	231,210
Stock-based compensation expense		144,504	106,435
Changes in operating assets and liabilities which used cash:
Accounts receivable		(856)	30,060
Prepaid expenses and other current assets		(65,057)	232,994
Accounts payable		(521)	95,878
Accrued compensation		205,575	30,090
Deferred revenue		(20,620)	15,925
Other accrued liabilities		(53,240)	(51,621)
Net cash and cash equivalents used in operating activities		(1,036,849)	(1,338,711)
Cash Flows from Investing Activities
Investment in capitalized software		(131,200)	(212,599)
Net cash and cash equivalents used in investing activities		(131,200)	(212,599)
Net decrease in cash, cash equivalents, and restricted cash		(1,168,049)	(1,551,310)
Cash, cash equivalents, and restricted cash - Beginning of period		2,433,418	2,171,016
Cash, cash equivalents, and restricted cash - End of period		$1,265,369	$619,706
SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING ACTIVITIES:
Issuance of common stock for public offering consulting expenses	$	-	$655,000

-6-

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.